Clovis Oncology Inc (NASDAQ:CLVS)
| 5.59 Delayed Data As of Oct 23 |  -0.04 / -0.71%Today’s Change | 2.93 Today|||52-Week Range 17.37 | -46.43% Year-to-Date |
Latest CLVS News | Press Releases
No recent news for Clovis Oncology Inc.
Today’s Trading
| Previous close | 5.63 |
| Today’s open | 5.65 |
| Day’s range | 5.37 - 5.65 |
| Volume | 154,640 |
| Average volume (3 months) | 4,609,818 |
| Market cap | $528.8M |
Data as of 4:00pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | -5.16% |
| Earnings growth (this year) | +41.57% |
| Earnings growth (next 5 years) | +66.08% |
| Revenue growth (last year) | +49.92% |
| P/E ratio | NM |
| Price/Sales | 3.93 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GTHXG1 Therapeutics Inc | -0.14 | -1.09% |
| ASMBAssembly Biosciences... | -0.52 | -3.37% |
| MNKDMannKind Corp | -0.05 | -2.38% |
| CRNXCrinetics Pharmaceut... | -0.62 | -4.25% |
Data as of 4:00pm ET, 10/23/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | -$1.00 |
| Annual revenue (last year) | $143.0M |
| Annual profit (last year) | -$400.4M |
| Net profit margin | -280.01% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
